Skip to content

To explore safety and performance of Under Water Seal Drainage System (Romo Seal) in Adult & Paediatric subjects in Indian Population.

A prospective, single arm, post market clinical follow-up of Under Water Seal Drainage System (Romo Seal) to explore its safety and performance in Adult & Paediatric subjects in Indian Population. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/03/063659
Enrollment
100
Registered
2024-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Romo Seal Adult- GS-5020, Romo Seal Midi- GS-5031, Romo Seal Kid- GS-5032.: Device maximum use duration is not more than 7 days. Control Intervention1: NA: NA

Sponsors

Romsons Group Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Males and Females Adult & Paediatric who are expected to undergo pleural and chest drainages for effective management of Chest Conditions. 2 Subject who can provide Informed Consent Form Adult in writing and medically in a position to undergo consent and screening process OR in case of Paediatrics parent of child LAR Legally Acceptable Representative can provide Informed Assent Form Child. 3 The subject who is willing and able to comply with the requirement of the follow-up OR in case of Paediatrics parent of child LAR Legally Acceptable Representative who is willing and able to comply with the requirement of the follow-up.

Exclusion criteria

Exclusion criteria: 1 Subject who present with medical emergency where treatment is more priority than the informed consent informed assent process. 2 Subject who cannot provide Informed Consent Form Adult such as unconscious mentally challenged subject OR in case of Paediatrics parent of child LAR Legally Acceptable Representative who cannot provide Informed Assent Form Child or give permission etc. 3 Any known allergy with any of the material of Under Water Seal Drainage System Romo Seal and its components. 4 Other conditions which in the opinion of investigators make the patient unsuitable for enrolment or could interfere with his her participation in and completion of the clinical investigation plan protocol. 5 Subject who is pregnant or breastfeeding. 6 Subject is of childbearing potential and has a positive pregnancy test since admission to the hospital. 7 Participation in another research study involving an active investigation within 30 days prior to consent.

Design outcomes

Primary

MeasureTime frame
The Primary End Point of the study are as 1 Clinically intended for Under Water Seal Drainage procedure. 2 Facilitating unrestricted fluid drainage from the pleural cavity. 3 Facilitating the precise drained volume determination. 4 Improving the quality of life of the subject by achieving the intended purpose. Timepoint: Use duration of device is not more than 7 days.

Secondary

MeasureTime frame
The Secondary End Point of the study are as 1 Materials Compatibility with the tissue & body fluids. 2 Dedicated Suction port efficacy facilitating regulated suctioning for efficient drainage. 3 Durability Sustainability of Device & fitment of the accessories with standard devices over required period of use. Timepoint: Use duration of device is not more than 7 days.

Countries

India

Contacts

Public ContactDr Anoop Batra

Romsons Group Private Limited

singhalrohit10000@gmail.com8006599926

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026